Netzsch acquires Bruker's thermal analyzer business in Japan

Singapore: Netzsch Japan KK acquired Bruker Corporation's thermal analysis instruments business in Japan. Netzsch Japan ...

September 5, 2012 | Wednesday | News
Boston Scientific completes enrollment in SuperNOVA trial

Singapore: Boston Scientific has completed enrollment in the SuperNOVA trial - a global, single arm, prospective, multic...

August 21, 2013 | Wednesday | News
mHealth apps market to reach $20.7 bn by 2018: Report

Singapore: A recent report by Research and Markets estimates that global mHealth apps market will reach $6.6 billion in ...

October 22, 2013 | Tuesday | News
CSL Behring seeks Japan PMDA approval for Hemophilia drug

Global biotherapeutics company CSL Behring has submitted its new drug application (NDA) to Japan's Pharmaceuticals and M...

December 22, 2015 | Tuesday | News
BBK Worldwide opens Tokyo office; appoints new Managing Director

BBK Worldwide, a leading clinical trial marketing firm, has appointed Toshio Mori to Managing Director of Operations, Ja...

June 18, 2015 | Thursday | News
Gore's new endovascular therapy set to go for trials in Japan and US

W. L. Gore & Associates, Inc. (Gore) has announced that the Food and Drug Administration (FDA) has consented to the ...

June 18, 2015 | Thursday | News
Baylor Miraca Genetics appoints Gary Huff as President, CEO

Baylor Miraca Genetics Laboratories LLC (BMGL), a joint venture company between Japan-based Miraca Holdings and Baylor C...

June 18, 2015 | Thursday | News
Multiple myeloma treatment market to reach $8.9 bn by 2021, analyst

Singapore: Global multiple myeloma treatment market value will expand from $7.3 billion in 2014 to $8.9 billion by 2021,...

August 21, 2015 | Friday | Analysis
Teijin, Pulmagen enter agreement for asthma drug

Singapore: Tokyo-based Teijin Pharma, the core company of the Teijin Group's healthcare business, and Pulmagen Therapeu...

September 28, 2012 | Friday | News
Australian Cellmid acquires Japanese Advangen

Singapore: Australia-based Cellmid plans to acquire Japanese firm Advangen that owns the FGF-5 inhibitor hair growth tec...

May 9, 2013 | Thursday | News
Belgium 3D printing firm forays into Japan

Materialise NV, a Belgium-based provider of 3D software and sophisticated 3D printing solutions, and a pioneer in medica...

July 28, 2015 | Tuesday | News
Japan's Mitsubishi Tanabe pharma to revamp operations

Singapore: With a view to streamline operations and speed up new drug launches, Japan's Mitsubishi Tanabe pharma recentl...

July 28, 2015 | Tuesday | News
NTT's conductive fiber to help in biomedical recordings

Singapore: Japanese company Nippon Telegraph and Telephone Corporation (NTT) has developed a conductive fiber by coating...

March 21, 2013 | Thursday | News
Daiichi, ArQule enroll patient for cancer trial

Singapore: Daiichi Sankyo and ArQule announced that the first patient has been enrolled in the pivotal phase III METIV-...

February 1, 2013 | Friday | News
Three major Japanese labs collaborate on Parkinson's disease research

Tokyo: Sumitomo Dainippon Pharma Co. Ltd., Center for iPS Cell Research and Application, Kyoto University (CiRA) and Hit...

July 27, 2015 | Monday | News
BIO joins coalition to caution against further restructuring of Japan's Pharmaceutical Pricing

Biotechnology Industry Organization (BIO) has made an announcement that the organization has joined a coalition of organ...

July 31, 2015 | Friday | News
Japanese researchers discover potential drug target for muscle disease

Tokyo: In collaboration with the Institute for Frontier Medical Sciences at Kyoto University, a team of CiRA researchers...

August 24, 2015 | Monday | News
Biocon, Fujifilm launch Insulin Glargine in Japan

Singapore: Marking a major achievement in Indian biosimilar history, India's Biocon announced that close on the heels of...

July 19, 2016 | Tuesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls